US2004147563A1PendingUtilityA1

Use of thiazole deirvatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease

Priority: Jul 24, 2001Filed: Jul 16, 2002Published: Jul 29, 2004
Est. expiryJul 24, 2021(expired)· nominal 20-yr term from priority
A61K 31/4439A61P 11/06A61K 31/427A61P 11/00
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a useful and highly safe agent for curing chronic obstructive pulmonary disease, which contains, as the effective ingredient, at least one compound selected from the group consisting of thiazole derivatives and salts thereof represented by the general formula (1), wherein, R 1 is a phenyl group which may have 1 to 3 lower alkoxy groups as the substituents on the phenyl ring; R 2 is a pyridyl group which may have 1 to 3 carboxyl groups as the substituents on the pyridine ring.

Claims

exact text as granted — not AI-modified
1 . Use of a compound for the production of a medicament for the treatment of chronic obstructive pulmonary disease, which medicament comprises, as the effective ingredient, at least one compound selected from the group consisting of thiazole derivatives and salts thereof represented by the general formula (1),  
       
         
           
           
               
               
           
         
       
       wherein R 1  is a phenyl group which may have 1 to 3 lower alkoxy groups as the substituents on the phenyl ring; R 2  is a pyridyl group which may have 1 to 3 carboxyl groups as the substituents on the pyridine ring.  
     
     
         2 . The use according to  claim 1 , wherein the thiazole derivative is 6-[2-(3,4-diethoxyphenyl)-thiazol-4-yl]pyridine-2-carboxylic acid.

Join the waitlist — get patent alerts

Track US2004147563A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.